|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
20
|
|
pubmed:dateCreated |
2001-5-23
|
|
pubmed:databankReference |
|
|
pubmed:abstractText |
Pleiotrophin (PTN) is a secreted growth factor that induces neurite outgrowth and is mitogenic for fibroblasts, epithelial, and endothelial cells. During tumor growth PTN can serve as an angiogenic factor and drive tumor invasion and metastasis. To identify a receptor for PTN, we panned a phage display human cDNA library against immobilized PTN protein as a bait. From this we isolated a phage insert that was homologous to an amino acid sequence stretch in the extracellular domain (ECD) of the orphan receptor tyrosine kinase anaplastic lymphoma kinase (ALK). In parallel with PTN, ALK is highly expressed during perinatal development of the nervous system and down-modulated in the adult. Here we show in cell-free assays as well as in radioligand receptor binding studies in intact cells that PTN binds to the ALK ECD with an apparent Kd of 32 +/- 9 pm. This receptor binding is inhibited by an excess of PTN, by the ALK ECD, and by anti-PTN and anti-ECD antibodies. PTN added to ALK-expressing cells induces phosphorylation of both ALK and of the downstream effector molecules IRS-1, Shc, phospholipase C-gamma, and phosphatidylinositol 3-kinase. Furthermore, the growth stimulatory effect of PTN on different cell lines in culture coincides with the endogenous expression of ALK mRNA, and the effect of PTN is enhanced by ALK overexpression. From this we conclude that ALK is a receptor that transduces PTN-mediated signals and propose that the PTN-ALK axis can play a significant role during development and during disease processes.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0021-9258
|
|
pubmed:author |
pubmed-author:AignerAA,
pubmed-author:CaugheyD JDJ,
pubmed-author:KaravanovAA,
pubmed-author:KusMM,
pubmed-author:MalerczykCC,
pubmed-author:RiegelA TAT,
pubmed-author:SouttouBB,
pubmed-author:StoicaG EGE,
pubmed-author:SunithaII,
pubmed-author:WellsteinAA,
pubmed-author:WenDD
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
18
|
|
pubmed:volume |
276
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
16772-9
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:11278720-Adrenal Gland Neoplasms,
pubmed-meshheading:11278720-Animals,
pubmed-meshheading:11278720-Base Sequence,
pubmed-meshheading:11278720-Binding Sites,
pubmed-meshheading:11278720-Brain,
pubmed-meshheading:11278720-Carrier Proteins,
pubmed-meshheading:11278720-Cell Division,
pubmed-meshheading:11278720-Cell-Free System,
pubmed-meshheading:11278720-Cloning, Molecular,
pubmed-meshheading:11278720-Cytokines,
pubmed-meshheading:11278720-Gene Library,
pubmed-meshheading:11278720-Growth Substances,
pubmed-meshheading:11278720-Humans,
pubmed-meshheading:11278720-Kinetics,
pubmed-meshheading:11278720-Mice,
pubmed-meshheading:11278720-Molecular Sequence Data,
pubmed-meshheading:11278720-Protein-Tyrosine Kinases,
pubmed-meshheading:11278720-RNA, Messenger,
pubmed-meshheading:11278720-Receptor Protein-Tyrosine Kinases,
pubmed-meshheading:11278720-Recombinant Proteins,
pubmed-meshheading:11278720-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:11278720-Transcription, Genetic,
pubmed-meshheading:11278720-Transfection,
pubmed-meshheading:11278720-Tumor Cells, Cultured
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Identification of anaplastic lymphoma kinase as a receptor for the growth factor pleiotrophin.
|
|
pubmed:affiliation |
Lombardi Cancer Center, Georgetown University, Washington, DC 20007, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, U.S. Gov't, Non-P.H.S.,
Research Support, Non-U.S. Gov't
|
